ATE1799T1 - Aufloesbare thymidin-zusammensetzung und verfahren zu deren herstellung. - Google Patents

Aufloesbare thymidin-zusammensetzung und verfahren zu deren herstellung.

Info

Publication number
ATE1799T1
ATE1799T1 AT80300103T AT80300103T ATE1799T1 AT E1799 T1 ATE1799 T1 AT E1799T1 AT 80300103 T AT80300103 T AT 80300103T AT 80300103 T AT80300103 T AT 80300103T AT E1799 T1 ATE1799 T1 AT E1799T1
Authority
AT
Austria
Prior art keywords
thymidine
composition
production
solubilizing agent
soluble
Prior art date
Application number
AT80300103T
Other languages
English (en)
Inventor
Israel Marcus
Original Assignee
Israel Marcus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Israel Marcus filed Critical Israel Marcus
Application granted granted Critical
Publication of ATE1799T1 publication Critical patent/ATE1799T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT80300103T 1979-01-10 1980-01-10 Aufloesbare thymidin-zusammensetzung und verfahren zu deren herstellung. ATE1799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7900893 1979-01-10
EP80300103A EP0013625B1 (de) 1979-01-10 1980-01-10 Auflösbare Thymidin-Zusammensetzung und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE1799T1 true ATE1799T1 (de) 1982-12-15

Family

ID=10502427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300103T ATE1799T1 (de) 1979-01-10 1980-01-10 Aufloesbare thymidin-zusammensetzung und verfahren zu deren herstellung.

Country Status (6)

Country Link
US (1) US4368138A (de)
EP (1) EP0013625B1 (de)
AT (1) ATE1799T1 (de)
CA (1) CA1136550A (de)
DE (1) DE3061077D1 (de)
IL (1) IL59083A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405488A (en) * 1980-10-09 1983-09-20 Chisso Corporation Liquid-crystalline halogenobenzene derivatives
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
GB0213904D0 (en) * 2002-06-17 2002-07-31 Univ Sheffield Products useful in the treatment of MMR deficient tumours
US20030125283A1 (en) * 2002-09-16 2003-07-03 Gatenby Robert A. Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents
CA2539914A1 (en) * 2003-09-22 2005-04-07 Acidophil Llc Small molecule compositions and methods for increasing drug efficiency using compositions thereof
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL62992C (de) * 1946-05-27
DE947424C (de) * 1951-04-24 1956-08-16 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von Loesungen substituierter Xanthine
US2949449A (en) * 1959-01-14 1960-08-16 Hoffmann La Roche Synthesis of 3, 5-diaroyl-2-deoxy-d-ribofuranosyl ureas
DE1132925B (de) * 1960-02-19 1962-07-12 Bayer Ag Loesungsvermittler fuer wasserschwerloesliche organische Verbindungen
US3320236A (en) * 1963-03-07 1967-05-16 Miles Lab Reaction products of polymeric dialdehyde polysaccharides with p-aminosalicylates
FR1468708A (fr) * 1964-05-28 1967-02-10 Schwarz Biores Compositions contenant du sulfoxyde de diméthyle comme agent solubilisant
US3579453A (en) * 1968-11-12 1971-05-18 Rohm & Haas Alkali-soluble surfactant consisting of substituted succinic acid-nonionic ethoxylate blends
US3906043A (en) * 1969-06-12 1975-09-16 Israel Marcus Water-soluble tetracyclines
CA920124A (en) * 1969-06-12 1973-01-30 Marcus Israel Water-soluble tetracyclines
DE2147094A1 (de) * 1971-09-21 1973-04-05 Robugen Gmbh Virostatisch wirksames arzneimittel
DE2658406C2 (de) * 1975-12-31 1984-04-26 Asahi Kasei Kogyo K.K., Osaka Verfahren zur Herstellung wasserlöslicher Arzneimittelzubereitungen, enthaltend N↑4↑-Acylcytosin-arabinosid
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives

Also Published As

Publication number Publication date
EP0013625B1 (de) 1982-11-17
IL59083A0 (en) 1980-05-30
EP0013625A2 (de) 1980-07-23
EP0013625A3 (en) 1980-10-15
CA1136550A (en) 1982-11-30
US4368138A (en) 1983-01-11
DE3061077D1 (en) 1982-12-23
IL59083A (en) 1983-12-30

Similar Documents

Publication Publication Date Title
IL50485A (en) Compositions for sterilizing male anthers in plants comprising 3,4-methanopyrrolidine carboxylic acid derivatives
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
JPS5251327A (en) 3-trihydroxygermylpropionic acid and its salts and process for prepari ng the same
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ES8202015A1 (es) Un procedimiento para la preparacion de derivados de penici-lina
ATE1799T1 (de) Aufloesbare thymidin-zusammensetzung und verfahren zu deren herstellung.
ATE93228T1 (de) Geschuetzte aminosaeuren und verfahren zu ihrer herstellung.
ATE71362T1 (de) Salicylsaeureamide, verfahren zu ihrer herstellung und ihre verwendung.
IE37490B1 (en) Novel benzoic acid derivatives and benzisothiazole 1,1 dioxide derivatives
HK12681A (en) A 1,4-dihydropyridine-3.5-dicarboxylic acid di-ester derivative,several processes for its preparation,and its use as a coronary therapeutic agent
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
PT65578B (de) N-(1,2,4-triazin-5-on-4-yl)-glycin-derivate verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
IT1038688B (it) 1.2.4 triazolil i derivati processo per la loro preparazione loro impiego come sdiancanti ottici
ATE1521T1 (de) P-biphenyl-4-methyl-2-butensaeuren, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und deren verwendung.
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
SE7704480L (sv) Aminoalkoholer
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
SE7906681L (sv) Ftalazonderivat
JPS5242815A (en) Process for preparation of carboxylic acid esters
JPS5287116A (en) Novel physiologically active peptide
JPS523061A (en) Process for preparing 4-cyanoimidazole-5-carbamic acid esters
JPS5248640A (en) Process for preparation of alpha-substituted-phenyl-alkane-carboxylic acids their derivatives
JPS5283646A (en) N2-naphthalane sulphonyl-l-arginine derivative and acid addition salt thereof
SE7614755L (sv) Forening innehallande n 4-acylcytosinarabinosider och forfarande for framstellning derav
ES461718A1 (es) Procedimiento para la obtencion de composiciones herbicidas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee